CVE-2017-17677Not scoredCWE-732

CVE-2017-17677: Bmc Remedy Mid-Tier vulnerability

Bmc · Remedy Mid-Tier

Affected: Bmc Remedy Mid-Tier · Exploitation: possible (1 to 10%)

Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.

1.1%probability of exploitation in the next 30 days

65th percentile

050100

Higher than 65% of scored CVEs

Not scored yet. The CVE record carries no CVSS score.

DescriptionCVE.org

BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.

On the Atlas

Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.

Open the Atlas

Exploitation: Possible (1 to 10%). EPSS between 1% and 10%.
CISA KEV: Not listed
Public check: No public nuclei template
Weakness: Incorrect Permission Assignment for Critical Resource · Access Control
Vendor: Bmc
Published: May 2021
Band: Possible (1 to 10%), May 2021

CoverageNo articles yet

No CyberSIXT article names CVE-2017-17677 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.